Indeed, the discovery of recurrent alternate rearrangements that repose super-enhancers in the NFIB and TGFBR3 loci into proximity of MYB gene, uncovers an additional mechanism that may drive MYB overexpression in ACC tumors that do not express the fusion transcript [5]. This evidence concerns the gene MYB and adrenal cortex carcinoma.